Treatment of post-myocardial infarction depressive disorder

References

• Strik JMH, Lousberg R, Cherieux EC, Honig A. One year cumulative incidence of depression after myocardial infarction and impact on cardiac outcome. J. Psychosom. Res.56, 59–66 (2004).
   PubMed Web of Science ®Google Scholar
• Melle JP, van de Jonge P, Spijkerman TA et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom. Med.66, 814–822 (2004).
   PubMedGoogle Scholar
• Penninx BWJH, Beekman ATF, Honig A et al. Depression and cardiac mortality. Arch. Gen. Psychiatry58, 221–227 (2001).
   PubMed Web of Science ®Google Scholar
• McGovern PG, Pankow JS, Shahar E et al. Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors. N. Engl. J. Med.334, 884–890 (1996).
   PubMed Web of Science ®Google Scholar
• Rapaport MH, Judd LL, Shettler PJ et al. A descriptive analysis of minor depression. Am. J. Psychiatry159, 637–643 (2002).
   PubMed Web of Science ®Google Scholar
• Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA270, 1819–1825 (1993).
   PubMed Web of Science ®Google Scholar
• Berkman LF, Leo-Summers L, Horwitz RI. Emotional support and survival after myocardial infarction: a prospective, population-based study of the elderly. Ann. Intern. Med.117, 1003–1009 (1992).
   PubMed Web of Science ®Google Scholar
• Case RB, Moss AJ, Case N, McDermott M, Eberly S. Living alone after myocardial infarction. JAMA267, 515–519 (1992).
   PubMed Web of Science ®Google Scholar
• de Jonge P, Spijkerman TA, van den Brink RHS, Ormel J. Depression following myocardial infarction is a risk factor for declined health-related quality of life and increased disability and cardiac complaints at 12 months. Heart92, 32–39 (2006).
   PubMed Web of Science ®Google Scholar
• Carney RM, Blumenthal JA, Freedland KE et al.; for the ENRICHD Investigators. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) Study. Psychosom. Med.66, 466–474 (2004).
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. American Psychiatric Association, Washington, DC, USA. (1994).
   Google Scholar
• Strik JMH, Honig A, Lousberg R, Denollet J. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics42, 423–428 (2001).
   PubMed Web of Science ®Google Scholar
• van Melle JP, de Jonge P, Ormel J et al.; for the MIND-IT investigators. Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT. Eur. Heart J.26, 2650–2656 (2005).
   PubMed Web of Science ®Google Scholar
• de Jonge P, Ormel J, van den Brink RHS et al. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am. J. Psychiatry163, 138–144 (2006).
   PubMed Web of Science ®Google Scholar
• Wojciechowski FL, Strik JJMH, Falger P, Lousberg R, Honig A. The relationship between depressive and vital exhaustion symptomatology pot-myocardial infarction. Acta Psychiatrica Scand.102, 359–365 (2000).
   PubMed Web of Science ®Google Scholar
• Emons WH, Meijer RR, Denollet J. Negative affectivity and social inhibition in cardiovascular disease: evaluating type-D personality and its assessment using item response theory. J. Psychosom. Res.63(1), 27–39 (2007).
   PubMed Web of Science ®Google Scholar
• Denollet J. Type D personality. A potential risk factor refined. J. Psychosom. Res.49(4), 255–266 (2000).
   PubMed Web of Science ®Google Scholar
• Schiffer AA, Pedersen SS, Widdershoven JW, Hendriks EH, Winter JB, Denollet J. The distressed (type D) personality is independently associated with impaired health status and increased depressive symptoms in chronic heart failure. Eur. J. Cardiovasc. Prev. Rehabil.12, 341–346 (2005).
   PubMed Web of Science ®Google Scholar
• Honig A, Maes M. Psychoimmunology as common pathogenetic pathway in myocardial infarction, depression and cardiac death. Curr. Opin. Psychiatry13, 661–664 (2000).
   Web of Science ®Google Scholar
• Schins A, Tulner D, Lousberg R et al. Inflammatory markers in depressed post-myocardial infarction patients. J. Psychiatr. Res.39(2), 137–144 (2005); Erratum in: J. Psychiatr. Res.39(6), 633 (2005).
   PubMed Web of Science ®Google Scholar
• Schins A, Crijns HJ, Brummer R-J, Wichers M, Lousberg R, Celis S, Honig A. Altered omega-3 polyunsaturated fatty acid status in depressed post-myocardial infarction patients. Acta Psychiatrica Scand.115, 35–40 (2007).
   PubMedGoogle Scholar
• Schins A, Honig A, Crijns HJ, Hamulyák K. Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link? Psychosom. Med.65, 729–737 (2003).
   PubMedGoogle Scholar
• Schins A, Hamulyák K, Scharpé S et al. Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients. Life Sci.76, 637–650 (2004).
   PubMedGoogle Scholar
• Schins A, van Kroonenburgh M, van Laere K et al. Increased cerebral 5-HT 2A receptor binding in depressed patients with myocardial infarction. Psychiatry Res. Neuroimaging139, 155–163 (2005).
   Google Scholar
• Nakatani D, Sato H, Sakata Y et al. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am. Heart J.150, 652–658 (2005).
   PubMed Web of Science ®Google Scholar
• Otte C, McCaffery J, Ali S, Whooley MA. Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am. J. Psychiatry164, 1379–1384 (2007).
   PubMed Web of Science ®Google Scholar
• Maurer-Spurej E. Biomedicine and diseases: review; serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection. Cell Mol. Life Sci.62, 159–170 (2005).
   PubMedGoogle Scholar
• Strik JJ, Honig A, Lousberg R et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom. Med.62(6), 783–978 (2000).
   PubMed Web of Science ®Google Scholar
• Glassman AH, O’Connor CM, Califf RM et al.; for the Sertraline Antidepressant Heart Attack Randomized Trial Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA288, 701–709 (2002).
   PubMed Web of Science ®Google Scholar
• Writing Committee for the ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after myocardial infarction. JAMA289, 3106–3116 (2003).
   PubMed Web of Science ®Google Scholar
• Honig A, Kuyper AMG, Schene AH et al.; On behalf of the MIND-IT investigators. Treatment of post myocardial infarction depressive disorder: a randomized placebo controlled trial with mirtazapine. Pyschosom. Med.69, 606–613 (2007).
   PubMed Web of Science ®Google Scholar
• Lespérance F, Frasure-Smith N, Koszycki D et al.; for the CREATE investigators. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary disease. JAMA297, 367–379 (2007).
   PubMed Web of Science ®Google Scholar
• Roose SP, Laghrissi-Thode F, Kennedy JS et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA279, 287–291 (1998).
   PubMed Web of Science ®Google Scholar
• Benazon NR, Mamdani MM, Coyne JC. Trends in the prescribing of antidepressants following acute myocardial infarction, 1993–2002. Psychosom. Med.67, 916–920 (2005).
   PubMedGoogle Scholar